Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$7.15

-1.4 (-16.37%)

19:46
09/20/17
09/20
19:46
09/20/17
19:46

Iovance Biotherapeutics 7.69M share Secondary priced at $6.50

The deal priced at $6.50, below today's closing price of $7.15, which was a decline of over 16% on the trading day. Iovance Biotherapeutics intends to use the net proceeds from this offering to fund its current and future clinical trials for its product candidates, including its ongoing Phase 2 clinical trials of LN-144, TIL for treatment of metastatic melanoma, and LN-145, TIL for the treatment of cervical and head and neck cancers, to fund activities related to commercial scale-up of the company's TIL product manufacturing operations; and for working capital and other general corporate purposes. Jefferies and Wells Fargo acted as joint book running managers for the offering.

  • 25

    Sep

  • 21

    Sep

IOVA Iovance Biotherapeutics
$7.15

-1.4 (-16.37%)

08/03/17
OPCO
08/03/17
INITIATION
Target $13
OPCO
Outperform
Iovance Biotherapeutics initiated with an Outperform at Oppenheimer
Oppenheimer analyst Mark Breidenbach initiated Iovance Biotherapeutics with an Outperform and a $13 price target saying its tumor infiltrating lymphocytes therapy has been clinically validated by several academic institutions and expects to see a stream of clinical readouts from three ongoing company-sponsored trials in the next 12-18 month. Breidenbach expects lovance's path to commercialization in solid tumors to be simplified due to to the trailblazing of personalized CAR-T therapies for blood cancers.
08/31/17
HCWC
08/31/17
NO CHANGE
Target $16
HCWC
Buy
Iovance 'fired another shot across the bow of CAR-Ts,' says H.C. Wainwright
The approval of Novartis' (NVS) Kymriah is a "major leap forward" for oncology and immunotherapy, but there remains "significant room for differentiated products," H.C. Wainwright analyst Joseph Pantginis tells investors in a research note on Iovance Biotherapeutics (IOVA) titled "Pins Set Up: Kite Acquired and Kymriah Approved; TILs Can Knock 'Em Down; Reiterate Buy." The analyst believes Iovance's TILs, or tumor infiltrating lymphocytes, could be significantly differentiated from CAR-Ts like Kymriah. He says the TIL platform has a "significantly" more benign safety profile relative to CAR-Ts and growing evidence that it could effectively target solid tumors, an area where he thinks CAR-Ts continue to struggle. Pantginis thinks Iovance "fired another shot across the bow of CAR-Ts" with last night's ESMO conference abstracts. The company released preliminary data that it can generate highly active TILs from lymphoma tumors, the analyst contends. He reiterates a Buy rating on Iovance with a $16 price target. The shares closed yesterday down 30c to $5.55.
09/01/17
WELS
09/01/17
NO CHANGE
WELS
Outperform
Iovance fast track designation 'particularly validating,' says Wells Fargo
Wells Fargo analyst Jim Birchenough views Iovance Biotherapeutics' fast track designation from the FDA for its tumor infiltrating lymphocyte product LN-144 as "particularly validating for a novel cell therapy." The designation establishes unmet need for patients and could support a "more reasonable" Phase 3 hurdle, Birchenough tells investors in a research note. He has an Outperform rating on Iovance.
09/13/17
HCWC
09/13/17
NO CHANGE
Target $16
HCWC
Buy
Iovance expanding on multiple fronts, says H.C. Wainwright
Iovance Biotherapeutics released data at ESMO that it can generate highly active tumor infiltrating lymphocytes from lymphoma tumors, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note titled "Targeting Liquid Tumors and Automating the Supply Chain; Iovance Expanding on Multiple Fronts." The analyst says that while clinical efficacy of these expanded TILs remains unknown, he sees "significant safety profile differentiation" when compared to CAR-Ts. He notes that Iovance is also building new partnerships to make the supply chain run more efficiently. Pantginis keeps a Buy rating on the shares with a $16 price target.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/25/18
09/25
13:16
09/25/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
09/25/18
09/25
13:15
09/25/18
13:15
General news
Treasury's $38 B 5-year auction was disappointing »

Treasury's $38 B…

QEP

QEP Resources

$11.47

0.11 (0.97%)

13:10
09/25/18
09/25
13:10
09/25/18
13:10
Options
Second day of call buying in Qep Resources »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

13:04
09/25/18
09/25
13:04
09/25/18
13:04
General news
5-Yr Note Auction Coupon Rate data reported »

5-Yr Note Auction Coupon…

13:04
09/25/18
09/25
13:04
09/25/18
13:04
General news
5-Yr Note Auction Total Amount data reported »

5-Yr Note Auction Total…

VZ

Verizon

$53.49

-0.06 (-0.11%)

, MS

Morgan Stanley

$48.50

-0.06 (-0.12%)

13:02
09/25/18
09/25
13:02
09/25/18
13:02
Hot Stocks
Verizon names Chris Bartlett to lead corporate development at Verizon Ventures »

Verizon (VZ) has named…

VZ

Verizon

$53.49

-0.06 (-0.11%)

MS

Morgan Stanley

$48.50

-0.06 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Nov

  • 13

    Nov

ELAN

Elanco

$34.71

-0.19 (-0.54%)

13:01
09/25/18
09/25
13:01
09/25/18
13:01
Hot Stocks
Elanco expands commitment to fight antimicrobial resistance »

Elanco Animal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BP

BP

$46.36

1.135 (2.51%)

12:59
09/25/18
09/25
12:59
09/25/18
12:59
Periodicals
BP CEO sees larger impact from Iran oil sanctions than last time, Bloomberg says »

BP CEO Bob Dudley said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

12:55
09/25/18
09/25
12:55
09/25/18
12:55
General news
Treasury 5-year auction preview: the auction should go ok »

Treasury 5-year auction…

AOBC

American Outdoor Brands

$15.57

0.37 (2.43%)

12:52
09/25/18
09/25
12:52
09/25/18
12:52
Periodicals
American Outdoor investors approve call for gun safety report, Reuters says »

Investors at American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$51.81

-0.765 (-1.46%)

12:50
09/25/18
09/25
12:50
09/25/18
12:50
Options
Sizable ratio spread opened in the SPDR Utility Fund »

Sizable ratio spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$40.57

0.37 (0.92%)

12:48
09/25/18
09/25
12:48
09/25/18
12:48
Hot Stocks
GSK study says vaccine reduced incidence of tuberculosis in HIV negative adults »

GSK and Aeras reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 03

    Oct

ACAD

Acadia

$21.58

1.735 (8.74%)

12:45
09/25/18
09/25
12:45
09/25/18
12:45
Options
Acadia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ADP

ADP

$150.41

1.29 (0.87%)

, PAYX

Paychex

$75.26

0.7 (0.94%)

12:44
09/25/18
09/25
12:44
09/25/18
12:44
Hot Stocks
ADP, Paychex slip after Square introduces new payroll app »

Shares of traditional…

ADP

ADP

$150.41

1.29 (0.87%)

PAYX

Paychex

$75.26

0.7 (0.94%)

SQ

Square

$92.25

6.19 (7.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 11

    Oct

  • 22

    Oct

  • 31

    Oct

  • 26

    Nov

T

AT&T

$33.99

0.08 (0.24%)

, ERIC

Ericsson

$9.10

0.13 (1.45%)

12:44
09/25/18
09/25
12:44
09/25/18
12:44
Hot Stocks
AT&T, Ericsson team up on IoT cybersecurity »

AT&T (T) and Ericsson…

T

AT&T

$33.99

0.08 (0.24%)

ERIC

Ericsson

$9.10

0.13 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.35

0.26 (0.09%)

12:44
09/25/18
09/25
12:44
09/25/18
12:44
Periodicals
USTR says Canada not making necessary concessions for new NAFTA, Reuters says »

U.S. Trade Representative…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.35

0.26 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

D

Dominion

$69.54

-0.54 (-0.77%)

12:40
09/25/18
09/25
12:40
09/25/18
12:40
Periodicals
Dominion does not see court order delaying Atlantic Coast pipe, Reuters says »

Dominion Energy said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

MDR

McDermott

$18.75

0.36 (1.96%)

12:38
09/25/18
09/25
12:38
09/25/18
12:38
Hot Stocks
McDermott awarded contract by Bayport Polymers for new polyethylene plant »

McDermott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

T

AT&T

$33.98

0.07 (0.21%)

, ATUS

Altice USA

$18.69

0.07 (0.38%)

12:36
09/25/18
09/25
12:36
09/25/18
12:36
Hot Stocks
AT&T launches new advertising company called Xandr »

AT&T (T) announced…

T

AT&T

$33.98

0.07 (0.21%)

ATUS

Altice USA

$18.69

0.07 (0.38%)

FTR

Frontier Communications

$6.49

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

SQ

Square

$92.04

5.975 (6.94%)

12:34
09/25/18
09/25
12:34
09/25/18
12:34
Hot Stocks
Square introduces new payroll app for employers »

Square said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ULTA

Ulta Beauty

$277.98

-3.03 (-1.08%)

12:32
09/25/18
09/25
12:32
09/25/18
12:32
Conference/Events
Cowen retail/luxury analyst to hold an analyst/industry conference call »

Retail/Luxury Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ILIAF

Iliad

$0.00

(0.00%)

12:30
09/25/18
09/25
12:30
09/25/18
12:30
Downgrade
Iliad rating change  »

Iliad downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXP

Eagle Materials

$86.54

0.08 (0.09%)

12:27
09/25/18
09/25
12:27
09/25/18
12:27
Periodicals
Breaking Periodicals news story on Eagle Materials »

Hedgeye adds Eagle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

EA

Electronic Arts

$115.78

0.52 (0.45%)

, MSFT

Microsoft

$114.29

-0.43 (-0.37%)

12:26
09/25/18
09/25
12:26
09/25/18
12:26
Hot Stocks
Game On: Sony launching PlayStation Classic in December »

Welcome to "Game…

EA

Electronic Arts

$115.78

0.52 (0.45%)

MSFT

Microsoft

$114.29

-0.43 (-0.37%)

SNE

Sony

$58.61

1.75 (3.08%)

NTDOY

Nintendo

$0.00

(0.00%)

SGAMY

Sega Sammy Holdings

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$135.22

0.35 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

DDD

3D Systems

$20.19

1 (5.21%)

12:25
09/25/18
09/25
12:25
09/25/18
12:25
Options
3D Systems call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.